To better understand the molecular mechanisms underlying the dendritic cell (DC) defects in cancer, we analyzed which signaling pathway is implicated in the abnormal monocyte differentiation into DC determined by the presence of Primary effusion lymphoma (PEL) released factors. Our results indicate that the DC, obtained in this condition, together with phenotypic abnormalities and reduced allostimulatory function, showed hyperphosphorylation of signal transducer and activator of transcription 3 (STAT3) and p38 mitogen-activated protein kinase (MAPK) molecules, in comparison to the DC differentiated in the absence of PEL-released factors. The inhibition of p38 MAPK but not of STAT3 phosphorylation, with specific inhibitors, was able to revert the effect of the PEL-released factors on the DC phenotype. This study suggests that p38 MAPK signaling pathway is an important contributor to the abnormal differentiation of DC in PEL.
NadorRGCesarmanEChadburnADawsonDBSaldJKnowlesDM. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood1996; 88:645–56.
3.
EnsoliBStürzlMMoniniP. Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma. Seminars in Cancer Biology2000; 10:367–81.
4.
O'SheaJJGadinaMSchreiberRD. Cytokine signaling in new surprises in the Jak/Stat pathway. Cell2002; 109:S121–31.
5.
AokiYFeldmanGMTosatoG. Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymohoma. Blood2003; 101:1535–42.
6.
BrombrgJ. Stat proteins and oncogenesis. J Clin Invest2000; 109:1139–42.
7.
WangTNiuGKortylewskiM. Regulating of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med2004; 10:48–54.
BanchereauJBruireFCauxCDavoustJLebecqueSLiuYPulendranBPaludaK. Immunobiology of dendritic cells. Annu Rev Immunol2000; 18:767–811.
10.
NefedovaYHuangMKusmartsevSBattacharyaRChengPSalupRJoveRGabrilovichD. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. J Immunol2004; 172:464–74.
11.
NefedovaYChengPGilkesDBlaskovichMBegAASebtiSMGabrilovichD. Activation of dendritic cells via inhibition of Jak2/STAT3 signaling. J Immunol2005; 175:4338–64.
12.
WangSYangJQianJWezemanMKwakLWYiQ. Tumor evasion of the immune system: inhibiting p38 MAPK signaling restores the function of dendritic cells in multiple myeloma. Blood2006; 107:2432–9.
13.
WangSHongSYangJQianJZhangXShpallEKwakLWYiQ. Optimizing immunotherapy in multiple myeloma: Restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells. Blood2006; 108:4071–7.
14.
CironeMLucaniaGAleandriSBorgiaGTrivediPFratiLFaggioniA. Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma. Immunol Lett2008; 120:37–41.
15.
YoshimuraSBondesonJBrennanFMFoxwellBMFeldmannM. Role of NFkappaB in antigen presentation and development of regulatory T cells elucidated by treatment of dendritic cells with the proteasome inhibitor PSI. Eur J Immunol2001; 31:1883–93.
16.
XieJQianJYangJWangSFreemanMEIIIYiQ. Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells. Exp Hemathology2005; 33:564–72.
17.
ChoiYongwonBegAA. Dendritic Cell Development and Survival Require Distinct NF-kappaB Subunits. Immunity2002; 16:257–70.
18.
BharadwajULiMZhangRChenCYaoQ. Evated interleukin-6 and G-CSF in human pancreatic cancer cell conditioned medium suppress dendritic cell differentiation and activation. Cancer Res2007; 67:5479–88.
19.
OrsiniEGuariniAChiarettiSMauroFRFoaR. The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is defective and unable to stimulate an effective T-cell response. Cancer Res2003; 63:4497–506.
20.
YoshimuraSBondesonJFoxwellBMJBrennamFMFeldmannM. Effective antigen presentation by dendritic cells is NF-kappaB dependent: coordinate regulation of MHC, co-stimulatory molecules and cytokines. Int Immunol2001; 13:675–83.
21.
ArrighiJFRebsamenMRoussetFKindlerVHauserC. A critical role for p38 mitogen-activated protein kinase in the maturation of human blood-derived dendritic cells induced by lipopolysaccharide, TNF-alpha, and contact sensitizers. J Immunol2001; 166:3837–45.
22.
PanKWangHLiuW. The pivotal role of p38 and NF-kB signal pathways in the maturation of human monocyte-derived dendritic cells stimulated by streptococcal agent OK.-432. Immunobiol2009; 217:350–8.
23.
MeliefCJM. Cancer immunotherapy by dendritic cells. Immunity2008; 29:372–83.
